Limited effects of long-term daily cranberry consumption on the gut microbiome in a placebo-controlled study of women with recurrent urinary tract infections
Open Access
- 18 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Microbiology
- Vol. 21 (1), 1-17
- https://doi.org/10.1186/s12866-021-02106-4
Abstract
Urinary tract infections (UTIs) affect 15 million women each year in the United States, with > 20% experiencing frequent recurrent UTIs. A recent placebo-controlled clinical trial found a 39% reduction in UTI symptoms among recurrent UTI sufferers who consumed a daily cranberry beverage for 24 weeks. Using metagenomic sequencing of stool from a subset of these trial participants, we assessed the impact of cranberry consumption on the gut microbiota, a reservoir for UTI-causing pathogens such as Escherichia coli, which causes > 80% of UTIs. The overall taxonomic composition, community diversity, carriage of functional pathways and gene families, and relative abundances of the vast majority of observed bacterial taxa, including E. coli, were not changed significantly by cranberry consumption. However, one unnamed Flavonifractor species (OTU41), which represented ≤1% of the overall metagenome, was significantly less abundant in cranberry consumers compared to placebo at trial completion. Given Flavonifractor’s association with negative human health effects, we sought to determine OTU41 characteristic genes that may explain its differential abundance and/or relationship to key host functions. Using comparative genomic and metagenomic techniques, we identified genes in OTU41 related to transport and metabolism of various compounds, including tryptophan and cobalamin, which have been shown to play roles in host-microbe interactions. While our results indicated that cranberry juice consumption had little impact on global measures of the microbiome, we found one unnamed Flavonifractor species differed significantly between study arms. This suggests further studies are needed to assess the role of cranberry consumption and Flavonifractor in health and wellbeing in the context of recurrent UTI. Clinical trial registration number: ClinicalTrials.gov NCT01776021.Keywords
This publication has 148 references indexed in Scilit:
- Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformationProceedings of the National Academy of Sciences of the United States of America, 2013
- Effect of asiatic and ursolic acids on morphology, hydrophobicity, and adhesion of UPECs to uroepithelial cellsFolia Microbiologica, 2012
- Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platformsThe ISME Journal, 2012
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Recurrent Urinary Tract Infection and Urinary Escherichia coli in Women Ingesting Cranberry Juice Daily: A Randomized Controlled TrialMayo Clinic Proceedings, 2012
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- BEDTools: a flexible suite of utilities for comparing genomic featuresBioinformatics, 2010
- Effects of cranberry extracts and ursolic acid derivatives on P-fimbriatedEscherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-κβ transcriptional responsein vitroPharmaceutical Biology, 2009
- Optimization of terminal restriction fragment polymorphism (TRFLP) analysis of human gut microbiotaJournal of Microbiological Methods, 2007
- RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed modelsBioinformatics, 2006